UChicago Cancer
@uchicagocancer.bsky.social
Joint account for the NCI-designated UChicago Medicine Comprehensive Cancer Center and the University of Chicago's Section of Hematology/Oncology.
At the forefront of clinical care, research, and education. https://www.uchicagomedicine.org/cancer
At the forefront of clinical care, research, and education. https://www.uchicagomedicine.org/cancer
More than 100 UChicago Medicine doctors were named to Chicago's Cancer Fighters list. This reflects our deep commitment to delivering world-class cancer care, advancing research, and improving outcomes for every patient we serve. #CancerCare #TheCancerFighters
https://ow.ly/fVIC50XY3zH
https://ow.ly/fVIC50XY3zH
January 16, 2026 at 4:05 PM
More than 100 UChicago Medicine doctors were named to Chicago's Cancer Fighters list. This reflects our deep commitment to delivering world-class cancer care, advancing research, and improving outcomes for every patient we serve. #CancerCare #TheCancerFighters
https://ow.ly/fVIC50XY3zH
https://ow.ly/fVIC50XY3zH
A great new paper is here! Dr. @randysweismd.bsky.social is a lead author on a new piece in @natmed.nature.com about the multi-center Phase I DRAGON trial of linavonkibart for advanced solid tumors. Congratulations, Dr. Sweis!! The article can be read at: www.nature.com/articles/s41...
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial - Nature Medicine
In this multicenter phase 1 trial of patients with advanced solid tumors resistant to anti-PD-1 therapy, treatment with the anti-latent TGFβ1 antibody linavonkibart with or without pembrolizumab was s...
www.nature.com
January 15, 2026 at 6:58 PM
A great new paper is here! Dr. @randysweismd.bsky.social is a lead author on a new piece in @natmed.nature.com about the multi-center Phase I DRAGON trial of linavonkibart for advanced solid tumors. Congratulations, Dr. Sweis!! The article can be read at: www.nature.com/articles/s41...
Just under 2 months to go until the Organ Preservation & Survival in Head & Neck Cancer Conference!! Learn more & register at cme.uchicago.edu/OPSHNC26
Co-led by Drs. @arirosenbergmd.bsky.social, Vokes, Juloori, & Agrawal!
Co-led by Drs. @arirosenbergmd.bsky.social, Vokes, Juloori, & Agrawal!
Organ Preservation and Survival in Head and Neck Cancer | Center for Continuing Medical Education
David Rubenstein Forum | Chicago, IL This activity will enhance participant understanding of both established and emerging strategies in head and neck cancer care.
cme.uchicago.edu
January 14, 2026 at 7:53 PM
Just under 2 months to go until the Organ Preservation & Survival in Head & Neck Cancer Conference!! Learn more & register at cme.uchicago.edu/OPSHNC26
Co-led by Drs. @arirosenbergmd.bsky.social, Vokes, Juloori, & Agrawal!
Co-led by Drs. @arirosenbergmd.bsky.social, Vokes, Juloori, & Agrawal!
January marks #CervicalCancerAwarenessMonth.
Almost all cases of cervical cancer are caused by an #HPV infection. UChicago Cancer offers Pap smears, HPV tests, and screening exams at several locations throughout the greater Chicago area.
Learn more: https://ow.ly/vQML50XWjrf
Almost all cases of cervical cancer are caused by an #HPV infection. UChicago Cancer offers Pap smears, HPV tests, and screening exams at several locations throughout the greater Chicago area.
Learn more: https://ow.ly/vQML50XWjrf
January 13, 2026 at 6:22 PM
January marks #CervicalCancerAwarenessMonth.
Almost all cases of cervical cancer are caused by an #HPV infection. UChicago Cancer offers Pap smears, HPV tests, and screening exams at several locations throughout the greater Chicago area.
Learn more: https://ow.ly/vQML50XWjrf
Almost all cases of cervical cancer are caused by an #HPV infection. UChicago Cancer offers Pap smears, HPV tests, and screening exams at several locations throughout the greater Chicago area.
Learn more: https://ow.ly/vQML50XWjrf
Reposted by UChicago Cancer
🏆 Maryellen Giger: The 2026 SPIE Gold Medal
For pioneering work in computer-aided diagnosis and image analysis/AI, significant impact on clinical translation, & supporting the next generation of medical-imaging scientists and the SPIE community. @uchicagocancer.bsky.social
spie.org/news/maryell...
For pioneering work in computer-aided diagnosis and image analysis/AI, significant impact on clinical translation, & supporting the next generation of medical-imaging scientists and the SPIE community. @uchicagocancer.bsky.social
spie.org/news/maryell...
January 8, 2026 at 7:07 PM
🏆 Maryellen Giger: The 2026 SPIE Gold Medal
For pioneering work in computer-aided diagnosis and image analysis/AI, significant impact on clinical translation, & supporting the next generation of medical-imaging scientists and the SPIE community. @uchicagocancer.bsky.social
spie.org/news/maryell...
For pioneering work in computer-aided diagnosis and image analysis/AI, significant impact on clinical translation, & supporting the next generation of medical-imaging scientists and the SPIE community. @uchicagocancer.bsky.social
spie.org/news/maryell...
New article(s) alert!! From Dr. Kosuri, we have a paper in @ash.hematology.org's Blood about the PRECISION-T trial where he's a co-author (doi.org/10.1182/bloo...) and an invited commentary in @jamaoncology.com where he is first author (jamanetwork.com/journals/jam...)! Congratulations, Dr. Kosuri!!
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial
Key Points. In a randomized ph3 study, Orca-T significantly improved survival free cGVHD compared to conventional alloHSCT with Tac/MTX.In addition to lowe
doi.org
January 12, 2026 at 4:19 PM
New article(s) alert!! From Dr. Kosuri, we have a paper in @ash.hematology.org's Blood about the PRECISION-T trial where he's a co-author (doi.org/10.1182/bloo...) and an invited commentary in @jamaoncology.com where he is first author (jamanetwork.com/journals/jam...)! Congratulations, Dr. Kosuri!!
John Balogh didn't hesitate to enroll in the LO-RADS clinical trial for prostate cancer, which uses cutting-edge imaging and targeted radiation to treat cancer without compromising quality of life. Now 76, he is cancer-free, and fully back to living life.
https://ow.ly/WrLL50XTyuZ
https://ow.ly/WrLL50XTyuZ
January 8, 2026 at 6:52 PM
John Balogh didn't hesitate to enroll in the LO-RADS clinical trial for prostate cancer, which uses cutting-edge imaging and targeted radiation to treat cancer without compromising quality of life. Now 76, he is cancer-free, and fully back to living life.
https://ow.ly/WrLL50XTyuZ
https://ow.ly/WrLL50XTyuZ
Congratulations to Sonia Kupfer, MD, Peter O'Donnell, MD, and Russell Szmulewitz, MD on receiving new named professorships in 2026! This honor recognizes their outstanding contributions to cancer research and cancer care. @uchicagomedicine.bsky.social
https://ow.ly/NTXx50XSCaa
https://ow.ly/NTXx50XSCaa
January 6, 2026 at 7:21 PM
Congratulations to Sonia Kupfer, MD, Peter O'Donnell, MD, and Russell Szmulewitz, MD on receiving new named professorships in 2026! This honor recognizes their outstanding contributions to cancer research and cancer care. @uchicagomedicine.bsky.social
https://ow.ly/NTXx50XSCaa
https://ow.ly/NTXx50XSCaa
Read the inspiring journey of Wendy Stock, MD, highlighting her pioneering work in leukemia treatment, compassionate approach to patient care, and impactful mentorship that has shaped the next generation of oncologists.
OncLive
https://ow.ly/2gB050XS4Ts
OncLive
https://ow.ly/2gB050XS4Ts
January 6, 2026 at 3:20 PM
Read the inspiring journey of Wendy Stock, MD, highlighting her pioneering work in leukemia treatment, compassionate approach to patient care, and impactful mentorship that has shaped the next generation of oncologists.
OncLive
https://ow.ly/2gB050XS4Ts
OncLive
https://ow.ly/2gB050XS4Ts
Read the inspiring journey of Wendy Stock, MD, highlighting her pioneering work in leukemia treatment, compassionate approach to patient care, and impactful mentorship that has shaped the next generation of oncologists.
OncLive
https://ow.ly/2gB050XS4Ts
OncLive
https://ow.ly/2gB050XS4Ts
January 5, 2026 at 5:56 PM
Read the inspiring journey of Wendy Stock, MD, highlighting her pioneering work in leukemia treatment, compassionate approach to patient care, and impactful mentorship that has shaped the next generation of oncologists.
OncLive
https://ow.ly/2gB050XS4Ts
OncLive
https://ow.ly/2gB050XS4Ts
🔥Hot off the press: A new study by Freeman et al. in JAMA Network Open highlights that adjuvant chemotherapy use in breast cancer has become increasingly guided by lymph node status and genomic risk—particularly among premenopausal women.
https://ow.ly/uB4050XNPP0
https://ow.ly/uB4050XNPP0
December 23, 2025 at 8:12 PM
🔥Hot off the press: A new study by Freeman et al. in JAMA Network Open highlights that adjuvant chemotherapy use in breast cancer has become increasingly guided by lymph node status and genomic risk—particularly among premenopausal women.
https://ow.ly/uB4050XNPP0
https://ow.ly/uB4050XNPP0
Researchers from UChicago Medicine shared key breakthroughs at #ASH2025, including early-line CAR T-cell use in myeloma, novel leukemia studies, outcomes in blood cancers, real-world monoclonal antibody data, and more.
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/EzRt50XNkMZ
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/EzRt50XNkMZ
December 22, 2025 at 6:12 PM
Researchers from UChicago Medicine shared key breakthroughs at #ASH2025, including early-line CAR T-cell use in myeloma, novel leukemia studies, outcomes in blood cancers, real-world monoclonal antibody data, and more.
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/EzRt50XNkMZ
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/EzRt50XNkMZ
Congratulations to Dr. @fredhow.bsky.social who received a 2025 SABCS Rising Stars Award at this year's San Antonio Breast Cancer Symposium!! He presented his work "Digital Histology Models Predict Chemotherapy Benefit in Randomized Adjuvant Trials and Real-World Cohorts"!
#RisingStars #SABCS25
#RisingStars #SABCS25
December 10, 2025 at 9:54 PM
Congratulations to Dr. @fredhow.bsky.social who received a 2025 SABCS Rising Stars Award at this year's San Antonio Breast Cancer Symposium!! He presented his work "Digital Histology Models Predict Chemotherapy Benefit in Randomized Adjuvant Trials and Real-World Cohorts"!
#RisingStars #SABCS25
#RisingStars #SABCS25
We’re excited to announce that board-certified surgical oncologist Ryan Merkow, MD, MS, has opened a new clinic in Northbrook, bringing his expertise in treating complex gastrointestinal cancers closer to home for patients in the northern suburbs. Schedule an appt: 773-834-3524
December 10, 2025 at 4:26 PM
We’re excited to announce that board-certified surgical oncologist Ryan Merkow, MD, MS, has opened a new clinic in Northbrook, bringing his expertise in treating complex gastrointestinal cancers closer to home for patients in the northern suburbs. Schedule an appt: 773-834-3524
In just a few months the Organ Preservation & Survival in Head & Neck Cancer Conference will be here on campus!! Join our experts, including Drs. Vokes, Rosenberg, Agrawal, and Juloori, on March 6! Learn more at cme.uchicago.edu/OPSHNC26
December 10, 2025 at 3:54 PM
In just a few months the Organ Preservation & Survival in Head & Neck Cancer Conference will be here on campus!! Join our experts, including Drs. Vokes, Rosenberg, Agrawal, and Juloori, on March 6! Learn more at cme.uchicago.edu/OPSHNC26
In a new study, Yuxuan Miao, PhD, and team identifies how tumor-initiating stem cells hijack nearby neutrophils to evade immunotherapy, suggesting that disrupting the defense mechanism may improve long-term outcomes. @uchicagomedicine.bsky.social UChicagoBSD
https://ow.ly/qOf050XCcfz
https://ow.ly/qOf050XCcfz
December 4, 2025 at 10:32 PM
In a new study, Yuxuan Miao, PhD, and team identifies how tumor-initiating stem cells hijack nearby neutrophils to evade immunotherapy, suggesting that disrupting the defense mechanism may improve long-term outcomes. @uchicagomedicine.bsky.social UChicagoBSD
https://ow.ly/qOf050XCcfz
https://ow.ly/qOf050XCcfz
🔥Hot off the press: Yuxuan Miao, PhD and colleagues have published a new study in Cancer Cell revealing how cancer-initiating stem cells support nearby neutrophils by supplying arachidonic acid—ultimately driving resistance to immunotherapy.
https://ow.ly/9E9W50XC1bV
https://ow.ly/9E9W50XC1bV
December 4, 2025 at 5:33 PM
🔥Hot off the press: Yuxuan Miao, PhD and colleagues have published a new study in Cancer Cell revealing how cancer-initiating stem cells support nearby neutrophils by supplying arachidonic acid—ultimately driving resistance to immunotherapy.
https://ow.ly/9E9W50XC1bV
https://ow.ly/9E9W50XC1bV
One of our pediatric patients - Ayden Newman - was spotlighted in the inaugural American Association for Cancer Research (AACR) Pediatric Cancer Progress Report, released today https://ow.ly/eQ1Z50XBUzK #PediatricCancerProgressReport
December 4, 2025 at 3:28 PM
One of our pediatric patients - Ayden Newman - was spotlighted in the inaugural American Association for Cancer Research (AACR) Pediatric Cancer Progress Report, released today https://ow.ly/eQ1Z50XBUzK #PediatricCancerProgressReport
Dr. Funmi Olopade was a co-author on a paper describing how a cellular protein, FGD3, boosts breast cancer chemotherapy and immunotherapy. Her lab provided the breast cancer patient-derived organoids for this study. news.illinois.edu/study-a-cell...
Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy – News Bureau
news.illinois.edu
December 3, 2025 at 5:11 PM
Dr. Funmi Olopade was a co-author on a paper describing how a cellular protein, FGD3, boosts breast cancer chemotherapy and immunotherapy. Her lab provided the breast cancer patient-derived organoids for this study. news.illinois.edu/study-a-cell...
New study reveals stark disparities in male breast cancer mortality, largely driven by socioeconomic factors. Asian and black men with triple-negative disease are also at higher risk, suggesting equity in care is critical. #BreastCancer #HealthEquity
https://ow.ly/qzMC50XAYF6
https://ow.ly/qzMC50XAYF6
December 2, 2025 at 10:01 PM
New study reveals stark disparities in male breast cancer mortality, largely driven by socioeconomic factors. Asian and black men with triple-negative disease are also at higher risk, suggesting equity in care is critical. #BreastCancer #HealthEquity
https://ow.ly/qzMC50XAYF6
https://ow.ly/qzMC50XAYF6
New article alert!! 🚨
Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...
#AtTheForefront #CancerResearch #CancerCare
Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...
#AtTheForefront #CancerResearch #CancerCare
Phase 1b Study of Dazostinag Plus Pembrolizumab After Hypofractionated Radiotherapy in Patients With Select Advanced Solid Tumors
Abstract. Purpose:
We present the preclinical rationale and clinical data from a phase 1b trial investigating the STING agonist dazostinag plus pembrolizumab following hypofractionated radiotherapy in...
doi.org
December 2, 2025 at 5:46 PM
New article alert!! 🚨
Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...
#AtTheForefront #CancerResearch #CancerCare
Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...
#AtTheForefront #CancerResearch #CancerCare
Two patients diagnosed with prostate cancer chose HIFU — a precise, non-invasive therapy — and both avoided major side effects while treating their cancer.
Learn how UChicago Medicine is leading the way in focal therapy: https://ow.ly/St3x50XxF0c
@UChicagoMedicine
Learn how UChicago Medicine is leading the way in focal therapy: https://ow.ly/St3x50XxF0c
@UChicagoMedicine
November 25, 2025 at 5:43 PM
Two patients diagnosed with prostate cancer chose HIFU — a precise, non-invasive therapy — and both avoided major side effects while treating their cancer.
Learn how UChicago Medicine is leading the way in focal therapy: https://ow.ly/St3x50XxF0c
@UChicagoMedicine
Learn how UChicago Medicine is leading the way in focal therapy: https://ow.ly/St3x50XxF0c
@UChicagoMedicine
Congratulations to Tre Jones for this award and we are grateful for his support of cancer research! https://nbpa.com/news/chicago-bulls-tre-jones-named-nba-cares-bob-lanier-community-assist-award-winner-for-october
CHICAGO BULLS’ TRE JONES NAMED NBA CARES BOB LANIER COMMUNITY ASSIST AWARD WINNER FOR OCTOBER
The National Basketball Players Association (NBPA) is the union for current professional basketball players in the National Basketball Association (NBA). Established in 1954, the NBPA mission is to ensure that the rights of NBA players are protected and that every conceivable measure is taken to assist players in maximizing their opportunities and achieving their goals, both on and off the court.
nbpa.com
November 25, 2025 at 3:56 PM
Congratulations to Tre Jones for this award and we are grateful for his support of cancer research! https://nbpa.com/news/chicago-bulls-tre-jones-named-nba-cares-bob-lanier-community-assist-award-winner-for-october
In a viewpoint, Sean Pitroda, MD and Ralph Weichselbaum, MD emphasizes the need to personalize treatment based on tumor biology, immune profiles, and metastatic patterns rather than relying on a single treatment. @JAMA Oncology Ludwig Cancer Research
https://ow.ly/BGBL50XvWcf
https://ow.ly/BGBL50XvWcf
November 21, 2025 at 5:39 PM
In a viewpoint, Sean Pitroda, MD and Ralph Weichselbaum, MD emphasizes the need to personalize treatment based on tumor biology, immune profiles, and metastatic patterns rather than relying on a single treatment. @JAMA Oncology Ludwig Cancer Research
https://ow.ly/BGBL50XvWcf
https://ow.ly/BGBL50XvWcf
A recent study published by Chuan He, PhD, and team reports that an ultra-mild bisulfite sequencing technique enables methylation sequencing both gentle and precise for ultra-low DNA inputs, providing a powerful tool to study epigenetic changes in cancer.
https://ow.ly/fMRw50XuP0f
https://ow.ly/fMRw50XuP0f
November 20, 2025 at 5:02 PM
A recent study published by Chuan He, PhD, and team reports that an ultra-mild bisulfite sequencing technique enables methylation sequencing both gentle and precise for ultra-low DNA inputs, providing a powerful tool to study epigenetic changes in cancer.
https://ow.ly/fMRw50XuP0f
https://ow.ly/fMRw50XuP0f